Selective activation of the mitogen-activated protein kinase subgroups c-Jun NH2 terminal kinase and p38 by IL-1 and TNF in human articular chondrocytes

被引:195
作者
Geng, Y
Valbracht, J
Lotz, M
机构
[1] UNIV CALIF SAN DIEGO, DEPT MED, SAM & ROSE STEIN INST RES AGING, LA JOLLA, CA 92093 USA
[2] UNIV CALIF SAN DIEGO, DEPT MED, DEPT MED, LA JOLLA, CA 92093 USA
关键词
interleukin-1; cartilage; MAP kinase; chondrocytes;
D O I
10.1172/JCI119056
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Previous studies suggested that tyrosine kinase activation is an important signal transduction event in the IL-1 response of chondrocytes. The present study identifies the mitogen-activated protein (MAP) kinases extracellular signal-regulated kinase (ERK)-1 and ERK-2 as major tyrosine phosphorylated proteins in IL-1 stimulated chondrocytes, Kinase assays on immunoprecipitates with myelin basic protein as substrate showed that ERK-1 and ERK-2 activation was detectable within 5 min after IL-1 stimulation and decreased to baseline within 60 min, Analysis of other members of the MAP kinase family showed that chondrocytes also express c-Jun NH, terminal kinase (JNK)-1, JNK-2, and p38 proteins. These kinases were time-dependently activated by IL-1, Among other chondrocyte activators tested, only TNF activated all three of the MAP kinase subgroups, JNK and p38 were not activated by any of the other cytokines and growth factors tested, However, ERK was also activated by PDGF, IGF-1, and IL-6. Phorbol 12-myristate 13-acetate, calcium ionophore, and cAMP analogues only increased ERK activity but had no significant effects on JNK or p38. These results suggest differential activation of MAP kinase subgroups by extracellular stimuli. ERK is activated in response to qualitatively diverse extracellular stimuli and various second messenger agonists, In contrast, JNK and p38 are only activated by IL-1 or TNF, suggesting that these kinases participate in the induction of the catabolic program in cartilage.
引用
收藏
页码:2425 / 2430
页数:6
相关论文
共 56 条
  • [1] INHIBITION OF INTERLEUKIN-1-INDUCED COLLAGENASE PRODUCTION IN HUMAN ARTICULAR CHONDROCYTES INVITRO BY RECOMBINANT HUMAN INTERFERON-GAMMA
    ANDREWS, HJ
    BUNNING, RAD
    PLUMPTON, TA
    CLARK, IM
    RUSSELL, RGG
    CAWSTON, TE
    [J]. ARTHRITIS AND RHEUMATISM, 1990, 33 (11): : 1733 - 1738
  • [2] MODULATION OF INTERLEUKIN-1-INDUCED ALTERATIONS IN CARTILAGE PROTEOGLYCAN METABOLISM BY ACTIVATION OF PROTEIN-KINASE-C
    ARNER, EC
    PRATTA, MA
    [J]. ARTHRITIS AND RHEUMATISM, 1991, 34 (08): : 1006 - 1013
  • [3] MEMBRANE TARGETING OF THE NUCLEOTIDE EXCHANGE FACTOR SOS IS SUFFICIENT FOR ACTIVATING THE RAS SIGNALING PATHWAY
    ARONHEIM, A
    ENGELBERG, D
    LI, NX
    ALALAWI, N
    SCHLESSINGER, J
    KARIN, M
    [J]. CELL, 1994, 78 (06) : 949 - 961
  • [4] INTERLEUKIN-1 AND ENDOTOXIN ACTIVATE SOLUBLE GUANYLATE-CYCLASE IN VASCULAR SMOOTH-MUSCLE
    BEASLEY, D
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 259 (01): : R38 - R44
  • [5] INTERLEUKIN-1 INDUCES PROLONGED L-ARGININE-DEPENDENT CYCLIC GUANOSINE-MONOPHOSPHATE AND NITRITE PRODUCTION IN RAT VASCULAR SMOOTH-MUSCLE CELLS
    BEASLEY, D
    SCHWARTZ, JH
    BRENNER, BM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (02) : 602 - 608
  • [6] INTERLEUKIN-1 ACTIVATES SOLUBLE GUANYLATE-CYCLASE IN HUMAN VASCULAR SMOOTH-MUSCLE CELLS THROUGH A NOVEL NITRIC OXIDE-INDEPENDENT PATHWAY
    BEASLEY, D
    MCGUIGGIN, M
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (01) : 71 - 80
  • [7] IL-1-INDUCED NITRIC-OXIDE INHIBITS CHONDROCYTE PROLIFERATION VIA PGE2
    BLANCO, FJ
    LOTZ, M
    [J]. EXPERIMENTAL CELL RESEARCH, 1995, 218 (01) : 319 - 325
  • [8] EPIDERMAL GROWTH-FACTOR REGULATES P21(RAS) THROUGH THE FORMATION OF A COMPLEX OF RECEPTOR, GRB2 ADAPTER PROTEIN, AND SOS NUCLEOTIDE EXCHANGE FACTOR
    BUDAY, L
    DOWNWARD, J
    [J]. CELL, 1993, 73 (03) : 611 - 620
  • [9] Chandrasekhar S, 1993, Agents Actions Suppl, V39, P121
  • [10] ARTHRITIS INDUCED BY INTERLEUKIN-1 IS DEPENDENT ON THE SITE AND FREQUENCY OF INTRAARTICULAR INJECTION
    CHANDRASEKHAR, S
    HARVEY, AK
    HRUBEY, PS
    BENDELE, AM
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1990, 55 (03): : 382 - 400